MyAverix Finance
HK · Healthcare
Fangzhou Inc (6086)
Pharmaceutical Retailers
Fangzhou Inc (6086) is listed on HK in the Healthcare sector. Industry: Pharmaceutical Retailers. As of 2026-05-21, reported market cap is $1.33B, P/E ratio is 96.00, net margin is 0.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6086
Fangzhou Inc (6086) — FAQ
What is Fangzhou Inc's market cap?
Fangzhou Inc (6086) has a reported market cap of $1.33B (data as of 2026-05-21).
What is 6086's P/E ratio?
The price-to-earnings (P/E) ratio for Fangzhou Inc (6086) is 96.00 (data as of 2026-05-21).
Does Fangzhou Inc pay a dividend?
Dividend yield is not available in the current snapshot for Fangzhou Inc (6086). Check the MyAverix Finance app for the latest dividend data.
What sector is Fangzhou Inc in?
Fangzhou Inc (6086) is classified in the Healthcare sector (Pharmaceutical Retailers industry).
What exchange is 6086 listed on?
6086 is listed on HK.
What is Fangzhou Inc's net margin?
Fangzhou Inc (6086) reports a net margin of 0.3% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.